Legal & General Group
ORTX

Legal & General Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Legal & General Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,142
Closed -$58K – 3710
2022
Q1 		$58K Hold
8,142
– – ﹤0.01% 2980
2021
Q4 		$108K Buy
8,142
+2,355
+41% +$38.9K ﹤0.01% 2895
2021
Q3 		$133K Buy
5,787
+736
+15% +$21.9K ﹤0.01% 2791
2021
Q2 		$221K Sell
5,051
-1,336
-21% -$74.4K ﹤0.01% 2513
2021
Q1 		$463K Buy
6,387
+670
+12% +$47.6K ﹤0.01% 2314
2020
Q4 		$246K Buy
5,717
+3,156
+123% +$141K ﹤0.01% 2379
2020
Q3 		$105K Hold
2,561
– – ﹤0.01% 2477
2020
Q2 		$154K Buy
2,561
+1,397
+120% +$128K ﹤0.01% 2418
2020
Q1 		$87K Buy
1,164
+342
+42% +$39.4K ﹤0.01% 2451
2019
Q4 		$113K Buy
822
+625
+317% +$76K ﹤0.01% 2559
2019
Q3 		$23K Buy
197
+30
+18% +$4.19K ﹤0.01% 3095
2019
Q2 		$23K Buy
+167
New +$29.3K ﹤0.01% 3153

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Legal & General Group's ORTX Position: Q2 2022 in Review

Legal & General Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 8,142 shares — an estimated $58K sold.

Legal & General Group first reported a position in ORTX in Q2 2019 and held it in 12 quarters. The position peaked at $463K in Q1 2021. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

  • Legal & General Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 8,142 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $58K.
  • Legal & General Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 12 quarters.
  • Legal & General Group's Orchard Therapeutics plc American Depositary Shares position peaked at $463K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.